On the other hand, however, we could show that chronic IL-17A stimulation in the context of other neuroinflammatory diseases, such as a LPS-sepsis model or cuprizone-induced demyelination, enhances neuroinflammatory responses (Zimmermann et al., 2018). Here, IL17A is linked to Sepsis.